Skip to main content

Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome

  • Chapter
Book cover Fundamentals of Family Medicine
  • 79 Accesses

Abstract

Care for patients with human immunodeficiency virus (HIV) infection requires excellence in all aspects of family practice. The family physician’s roles are many: providing patient education to prevent uninfected persons from becoming infected; identifying and instituting early intervention for infected persons; delivering comprehensive care of symptomatic disease including the acquired immunodeficiency syndrome (AIDS); and providing support and care for the family. This broad scope of clinical responsibilities is in an area of clinical medicine where the knowledge base and management strategies are evolving rapidly. New manifestations of HIV disease, diagnostic protocols, and drug recommendations (Table 21.2)1 change on a regular basis. Epidemiologic, social, and community trends also continue to have important effects on clinical care. This chapter provides an overview of important clinical aspects of HIV disease for the family physician.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldschmidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions: 1994. J Am Board Fam Pract 1994;7:155–78.

    PubMed  CAS  Google Scholar 

  2. Centers for Disease Control; Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(Suppl1):1S-15S.

    Google Scholar 

  3. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(Suppl6):1–37.

    Google Scholar 

  4. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39(No. RR-1):1–14.

    Google Scholar 

  5. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987;36:509–15.

    Google Scholar 

  6. Goldschmidt RH, Legg JJ. Counseling patients about HIV test results. J Am Board Fam Pract 1991;4:361–3.

    PubMed  CAS  Google Scholar 

  7. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38:236–8, 243–50.

    Google Scholar 

  8. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40(No. RR-5):27–33.

    Google Scholar 

  9. Sande MA, Carpenter CC, Cobbs CG, et al. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-infected Patients. JAMA 1993; 270:2583–9.

    Article  PubMed  CAS  Google Scholar 

  10. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322:941–9.

    Article  PubMed  CAS  Google Scholar 

  11. Concorde: MCR/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee. Lancet 1994;343:871–81.

    Article  Google Scholar 

  12. Caliendo AM, Hirsch MS. Combination therapy for infection due to human immunodeficiency virus type I. Clin Infect Dis 1994;18:516–24.

    Article  PubMed  CAS  Google Scholar 

  13. Hirsch MS, D’Aquila RT. Therapy for human immunodeficiency virus infection. N Engl J Med 1993;328:1686–95.

    Article  PubMed  CAS  Google Scholar 

  14. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992;41(No. RR-4):1–11.

    Google Scholar 

  15. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycrobacterium Avium Complex. MMWR 1993;42(RR-9): 14–20.

    Google Scholar 

  16. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med 1988;108:585–94.

    Article  PubMed  CAS  Google Scholar 

  17. Horsburgh Jr CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332–8.

    Article  PubMed  Google Scholar 

  18. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324: 1644–50.

    Article  PubMed  CAS  Google Scholar 

  19. Berger TG, Obuch ML, Goldschmidt RH. Dermatologic manifestations of HIV infection. Am Fam Physician 1990;41:1729–42.

    PubMed  CAS  Google Scholar 

  20. Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991;115:665–73.

    Article  PubMed  CAS  Google Scholar 

  21. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Am Rev Respir Dis 1990;141:1356–72, 1582–98.

    Article  PubMed  CAS  Google Scholar 

  22. Goldschmidt RH. Recommendations for the treatment of acute Pneumocystis carinii pneumonia. J Am Board Fam Pract 1991;4:58–60.

    PubMed  CAS  Google Scholar 

  23. National Institutes of Health—University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Carinii Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500–4.

    Article  Google Scholar 

  24. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989;86:539–46.

    Article  PubMed  CAS  Google Scholar 

  25. Spence MR, Reboli AC. Human immunodeficiency virus infection in women. Ann Intern Med 1991;115:827–9.

    Article  PubMed  CAS  Google Scholar 

  26. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83–89.

    Article  PubMed  CAS  Google Scholar 

  27. Centers for Disease Control and Prevention. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43(RR-11):1–20.

    Google Scholar 

  28. Falloon J, Eddy J, Wiener L, Pizzo PA. Human immunodeficiency virus infection in children. J Pediatr 1989;114:1–30.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goldschmidt, R.H. (1996). Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. In: Taylor, R.B. (eds) Fundamentals of Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2535-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-2535-3_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-94448-7

  • Online ISBN: 978-1-4757-2535-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics